Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Depomed Inc (NASDAQ:DEPO)

8.16
Delayed Data
As of Dec 14
 -0.29 / -3.43%
Today’s Change
4.31
Today|||52-Week Range
21.38
-54.72%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues123.9M90.4M100.5M95.4M
 
 
 
 
 
Cost of Goods Sold22.0M17.2M19.1M16.8M
 
 
 
 
 
Depreciation And Amortization26.4M26.3M26.3M26.3M
 
 
 
 
 
 
Operating ExpensesGross Income75.5M46.9M55.0M52.3M
 
 
 
 
 
General Expenses57.6M58.6M56.8M52.0M
 
 
 
 
 
Research And Development9.2M5.1M5.6M1.8M
 
 
 
 
 
Total Operating Expenses106.0M102.1M102.2M95.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income17.9M-11.7M-1.8M257.0K
 
 
 
 
 
Extraordinary Credit0.005.0M1.1M1.4M
 
 
 
 
Extraordinary Charge0.00-531.0K-9.1M-655.0K
 
 
 
 
Interest Expense On Debt20.5M19.6M17.5M17.6M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.5M-26.5M-26.9M-16.5M
 
 
 
 
 
Income Taxes-41.9M-202.0K-249.0K-513.0K
 
 
 
 
 
Net Income-44.4M-26.7M-26.7M-16.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS61.7M62.1M62.5M63.0M
 
 
 
 
 
Shares To Calculate EPS Diluted61.7M62.1M62.5M63.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.72-$0.43-$0.43-$0.25
 
 
 
 
 
EPS Diluted-$0.72-$0.43-$0.43-$0.25